Elixinol Wellness Expands Capital with New Shares

Elixinol Wellness Ltd (AU:EXL) has released an update.

Elixinol Wellness Ltd has announced the issuance of over 238 million new shares at $0.0045 each and nearly 80 million options exercisable at $0.0075, expiring in March 2027, as part of a placement strategy. The company confirms compliance with the necessary provisions of the Corporations Act and states there is no excluded information currently affecting the disclosure. This capital raising initiative is set to bolster Elixinol’s position in the global hemp industry, where it operates a vertically integrated business across nutrition, wellness, and superfood ingredients.

For further insights into AU:EXL stock, check out TipRanks’ Stock Analysis page.